Oral Semaglutide Yields Excellent CV Outcomes in High-Risk Type 2 Diabetes
The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease.
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 5055 results for 'type 2 diabetes '
Gut microbiome links obesity to type 2 diabetes: insights from Mendelian randomization.
Research has established links between the gut microbiome (GM) and both obesity and type 2 diabetes (T2D), which is much discussed, but underexplored. This study employed body mass index (BMI) as the measurement of obesity to...
Read More
Factors Behind Type 2 Diabetes Referrals From General Practitioners to Specialists
The following is a summary of “Referral reasons of type 2 diabetes patients from general...
Read More
Certain Combinations of Food Additives May Increase Risk for Type 2 Diabetes
WEDNESDAY, April 16, 2025 (HealthDay News) — Two widely consumed food additive mixtures may...
Read More
Alcohol Use and Glycemic Control in Type 2 Diabetes
The following is a summary of “Low-moderate alcohol use effects on glycemic control of patients...
Read More
Advancing Strategies for Type 2 Diabetes Prevention and Treatment
The following is a summary of “Trending Modalities in Type 2 Diabetes Prevention,” published in...
Read More
Patient Decision Aid Development for Type 2 Diabetes Based on IPDAS Standards
The following is a summary of “Development of a patient decision aid for type 2 diabetes mellitus:...
Read MoreAssociation between asthma and type 2 diabetes in a Swedish adult population: a register-based cross-sectional study.
Asthma and type 2 diabetes are two important causes of morbidity globally. We examined both the association of type 2 diabetes with asthma in Swedish adults and the familial co-aggregation of the diseases.We conducted a...
Read More
Preventing Erectile Dysfunction in Men With Type 2 Diabetes
New research published in Endocrine revealed findings that may contribute to preventing erectile dysfunction in men with type 2 diabetes.
Read MoreAdvertisement
GLP-1 Receptor Agonists and Hematologic Cancer Risk in Type 2 Diabetes
The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed...
Read More
SGLT2 Inhibition Reduces Insulin Use in CKD and Type 2 Diabetes
The following is a summary of “Effects of SGLT2 inhibition on insulin use in CKD and type 2...
Read More
Glycemic and Weight Management in Type 2 Diabetes in Primary Care Settings
The following is a summary of “Glycemic and weight control in people with type 2 diabetes: A...
Read More
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
TUESDAY, Feb. 11, 2025 (HealthDay News) — Age differences are seen in the efficacy of...
Read More
Urinary Creatinine as a Biomarker for Diabetic Kidney Disease in Type 2 Diabetes
The following is a summary of “Non-linear relationship between urinary creatinine and diabetic...
Read More
Micronutrient Deficiencies Seen in More Than 45 Percent With Type 2 Diabetes
THURSDAY, Jan. 30, 2025 (HealthDay News) — More than 45 percent of patients with type 2...
Read More
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — A popular diabetes drug just got a major new...
Read More
Type 2 Diabetes and Major Cardiovascular Events in Atherosclerosis
The following is a summary of “Contribution of type 2 diabetes to major adverse cardiovascular...
Read MoreAssessing the risk of heart failure in type 2 diabetes: a prediction algorithm to sustain the evaluation of NT-proBNP in primary care.
Heart failure (HF) is a disease that leads to approximately 300,000 fatalities annually in Europe and 250,000 deaths each year in the United States. Type 2 Diabetes Mellitus (T2DM) is a significant risk factor for HF, and...
Read More
Early Type 2 Diabetes Diagnosis Increases Mortality and Cardiovascular Risk
The following is a summary of “Age at type 2 diabetes diagnosis and the risk of mortality among US...
Read More
BPROAD: Intensive or Standard BP Treatment Strategy in Type 2 Diabetes?
In the BPROAD study, an intensive blood pressure lowering treatment strategy led to less major cardiovascular events in patients with type 2 diabetes.
Read More